SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-029176
Filing Date
2023-06-21
Accepted
2023-06-21 16:36:25
Documents
12
Period of Report
2023-06-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K crnx-20230616.htm   iXBRL 8-K 90515
  Complete submission text file 0000950170-23-029176.txt   208851

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crnx-20230616.xsd EX-101.SCH 2472
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crnx-20230616_lab.xml EX-101.LAB 13474
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crnx-20230616_pre.xml EX-101.PRE 9902
6 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20230616_htm.xml XML 4777
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 231030378
SIC: 2834 Pharmaceutical Preparations